FidoCure®
AI-enabled precision medicine platform for canine cancer: Fighting cancer on both ends of the leash.
Palo Alto, United States
22 employees
Series Unknown
Total: $15.00M
Health Care
General Information
Get notified when FidoCure® moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track FidoCure®
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Health Care
About FidoCure®
Taxonomy: Precision Medicine, Canine Cancer, Next Generation DNA Sequencing, Veterinary Oncology, Personalized Treatment, Canine Genomics, Cancer Care, Biotech, Investment, Technology, Peer-Reviewed Research, Medical Innovation, Venture Capital
Funding Rounds & Investors (7)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
19 Jul 2022 |
| Venture Round | •••••• | 2 |
|
04 Mar 2022 |
| Series A | •••••• | 8 |
|
29 Oct 2020 |
| Non Equity Assistance | •••••• | 1 |
|
31 Jan 2019 |
| Seed Round | •••••• | 6 |
|
23 Jan 2019 |
FidoCure® Alternatives & Competitors
Vuja De is dedicated to developing cancer metastasis treatments that prevent cancer progression and...
Raising funds to eliminate cancer as a major health problem in dogs through education, outreach, and...
Specializing in Cancer Care & Diseases of the Blood
vs
BostonGene
FAQ About FidoCure®
Don't just browse. Track.
Signal Tracker monitors FidoCure® and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.